Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...

Celý popis

Podrobná bibliografie
Hlavní autoři: Liang Yen Liu, Matthew S Ji, Nhung T Nguyen, Frances E Chow, Donna M Molaie, Sean T Pianka, Richard M Green, Linda M Liau, Benjamin M Ellingson, Phioanh L Nghiemphu, Timothy F Cloughesy, Albert Lai
Médium: Článek
Jazyk:English
Vydáno: Taylor & Francis Group 2019-06-01
Edice:CNS Oncology
Témata:
bevacizumab
glioblastoma
glioma
long term
progression
recurrence
On-line přístup:https://www.futuremedicine.com/doi/10.2217/cns-2019-0007

Podobné jednotky

Podobné jednotky